mhurhangee/ep-ind-claims huggingface dataset:
A method of producing a seaweed-based powder having a critical gelling concentration (C 0) of at most 0.1 wt% wherein C 0 is measured according to the methods described in the "METHODS OF MEASUREMENT" section and having a storage modulus (G') of at least 30 Pa, as determined on a solution of reconstituted skimmed milk containing 0.3 wt% of said powder relative to the total weight of said solution, wherein the skimmed milk was reconstituted by dissolving powdered skimmed milk at 10% w/w in ultrapure water having 18.2 MΩ.cm resistivity, under stirring for 4 hours at room temperature, wherein G' is measured according to the methods described in the "METHODS OF MEASUREMENT" section, comprising at least 80% dry basis of particles of a macroscopic, multicellular marine algae (seaweed) belonging to Rhodophyta phylum, said method comprising the steps of: a. Providing a biomass containing seaweed and water, and having a dry solids content of at least 5 wt%. b. Subjecting the biomass to an exudation process to exude the water present inside the seaweed and obtaining an exudated biomass containing an exudated seaweed; c. Optionally drying the exudated biomass to a moisture level of at most 40 wt% to obtain a dried, exudated biomass; d. Cooking the exudated biomass in a brine solution to obtain a cooked biomass; e. Optionally washing and/or drying the cooked biomass; and f. Transforming the cooked biomass of step d) or e) into a seaweed-based powder. a. Providing a biomass containing seaweed and water, and having a dry solids content of at least 5 wt%. b. Subjecting the biomass to an exudation process to exude the water present inside the seaweed and obtaining an exudated biomass containing an exudated seaweed; c. Optionally drying the exudated biomass to a moisture level of at most 40 wt% to obtain a dried, exudated biomass; d. Cooking the exudated biomass in a brine solution to obtain a cooked biomass; e. Optionally washing and/or drying the cooked biomass; and f. Transforming the cooked biomass of step d) or e) into a seaweed-based powder.
Method for counting steps taken by a user, said method being implemented by a first portable electronic device formed by a personal activity monitor intended to be rather rigidly associated with the body of the user, and by a second portable electronic device formed by a smartphone, the first and second devices being configured to exchange data over a wireless connection, the first device comprising a first local clock for time-stamping collected data, and the second device comprising a second local clock for time-stamping collected data, whereby the timestamps for the data collected by the two devices are referenced to a common absolute time, the method comprising the steps of: /a1/ detecting and counting the steps of the user, by the first device, with at least one associated timestamp information, /a2/ detecting and counting the steps of the user, by the second device, with at least one associated timestamp information, /b/ transferring step data from one of the two devices to the other of the two devices, /c/ identifying at least a first time period (Tw) for which it is determined that a difference in the number of steps counted by the first device and by the second device is greater than a predetermined threshold, /d/ supplementing the step data recorded for said first time period in one of the two devices, with the step data from the other of the two devices. /a1/ detecting and counting the steps of the user, by the first device, with at least one associated timestamp information, /a2/ detecting and counting the steps of the user, by the second device, with at least one associated timestamp information, /b/ transferring step data from one of the two devices to the other of the two devices, /c/ identifying at least a first time period (Tw) for which it is determined that a difference in the number of steps counted by the first device and by the second device is greater than a predetermined threshold, /d/ supplementing the step data recorded for said first time period in one of the two devices, with the step data from the other of the two devices.
Frame for a drawer (4, 5), which has an outer shell and an inner shell, wherein the outer shell has an outer wall section which substantially or completely forms the visible outer wall of the frame and has an upper edge which extends, in use, approximately parallel to the drawer bottom, wherein the outer shell is displaceably guided relative to the inner shell and wherein the outer shell and the inner shell form a cavity therebetween which has one or more functional devices, and wherein the outer shell, in a first position relative to the inner shell, prevents access to the one functional device or at least one of the plurality of functional devices and covers the latter, wherein the outer shell and/or inner shell has an opening via which access to the one functional device or at least one of the plurality of functional devices is made possible in a second position, which is displaced in the longitudinal direction of the frame relative to the first position, so that the one or the plurality of functional devices, in the second position or sliding position of the outer shell relative to the inner shell, is or are accessible in each case via the opening, characterized in that the one or the plurality of functional device(s) are designed as adjusting device(s), and in that the opening is used for actuating the one or more adjusting device(s) with a tool.
A compound of Formula I, or a pharmaceutically acceptable salt or ester thereof wherein each K is independently N or CH; Q, T, U, V, W, X, Y and Z are independently selected from H, R, acyl, F, Cl, Br, I, OH, OR, NH 2, NHR, NR 2, SR, S 2 R, S-NHR, S 2 -NHR, S-NRR', S 2 -NRR', NHacyl, N(acyl) 2, CO 2 H, CO 2 R, R and R' are independently selected from straight chain, branched or cyclic alkyl or aralkyl groups, as well as aryl and heteroaryl groups; and R 1, R 2, R 3, R 4, R 5 and R 6 are independently selected from H, straight chain, branched or cyclic alkyl, aralkyl, aryl heteroaryl, acyl and imidoyl; for use in a method of treating or preventing hot flashes. or a pharmaceutically acceptable salt or ester thereof wherein each K is independently N or CH; Q, T, U, V, W, X, Y and Z are independently selected from H, R, acyl, F, Cl, Br, I, OH, OR, NH 2, NHR, NR 2, SR, S 2 R, S-NHR, S 2 -NHR, S-NRR', S 2 -NRR', NHacyl, N(acyl) 2, CO 2 H, CO 2 R, R and R' are independently selected from straight chain, branched or cyclic alkyl or aralkyl groups, as well as aryl and heteroaryl groups; and R 1, R 2, R 3, R 4, R 5 and R 6 are independently selected from H, straight chain, branched or cyclic alkyl, aralkyl, aryl heteroaryl, acyl and imidoyl; for use in a method of treating or preventing hot flashes.
A manufacturing arrangement realised for the manufacture of a rotor blade, comprising - a pair of tracks (11A, 11B) arranged along the longitudinal sides of a blade mould (M1, M2); - a first gantry assembly realised to span the track pair (11A, 11B) and to carry a first tool arrangement (20, 21), which first tool arrangement comprises at least a fibre distributor; - a second gantry assembly realised to span the track pair (11A, 11B) and to carry a second tool arrangement (30, 31) characterized in that said tool arrangement is realized to load a certain length of fibre mat into a fibre mat tool attachment for the fibre distributor; and - a control arrangement realised to effect a coordinated movement of the gantry assemblies (2, 3) along the track pair (11A, 11B) and to coordinate the operation of the second tool arrangement (30, 31) with the operation of the first tool arrangement (20, 21) by at least specifying the length of fibre mat according to the position of the first gantry assembly along the blade mould (M1, M2). - a pair of tracks (11A, 11B) arranged along the longitudinal sides of a blade mould (M1, M2); - a first gantry assembly realised to span the track pair (11A, 11B) and to carry a first tool arrangement (20, 21), which first tool arrangement comprises at least a fibre distributor; - a second gantry assembly realised to span the track pair (11A, 11B) and to carry a second tool arrangement (30, 31) characterized in that said tool arrangement is realized to load a certain length of fibre mat into a fibre mat tool attachment for the fibre distributor; and - a control arrangement realised to effect a coordinated movement of the gantry assemblies (2, 3) along the track pair (11A, 11B) and to coordinate the operation of the second tool arrangement (30, 31) with the operation of the first tool arrangement (20, 21) by at least specifying the length of fibre mat according to the position of the first gantry assembly along the blade mould (M1, M2).
A pharmaceutical composition for use in a method for the treatment of virus-induced disease, wherein the composition comprises an extract of Trigonella foenum-graecum and optionally pharmaceutically acceptable additives wherein the method comprises administration of between 20 mg and 250 mg Trigonella foenum-graecum extract at least once daily.
A mobile bulk material processing apparatus comprising: a mainframe mounting endless tracks or wheels to allow the apparatus to move over the ground; a hanging assembly having at least one material processing unit and a carrier frame, the carrier frame suspended from the mainframe via at least one support structure; a plurality of first couplings (303, 304) provided at the support structure and a plurality of complementary second couplings (500, 600) provided at the hanging assembly to releasably engage the first couplings (303, 304) to suspend the hanging assembly at the mainframe; a plurality of power operated actuators (302, 801) acting on the first (303, 304) and/or second (500, 600) couplings and powered by a motor to move at least one of the first (303, 304) and second (500, 600) couplings relative to one another to provide powered engagement and disengagement between the first (303, 304) and second (500, 600) couplings and to allow the hanging assembly to be connected and disconnected from the mainframe; characterised in that: the hanging assembly comprises at least a pair of telescopic arms mounted to extend from the carrier frame, each arm comprising one of the second couplings (500, 600). a mainframe mounting endless tracks or wheels to allow the apparatus to move over the ground; a hanging assembly having at least one material processing unit and a carrier frame, the carrier frame suspended from the mainframe via at least one support structure; a plurality of first couplings (303, 304) provided at the support structure and a plurality of complementary second couplings (500, 600) provided at the hanging assembly to releasably engage the first couplings (303, 304) to suspend the hanging assembly at the mainframe; a plurality of power operated actuators (302, 801) acting on the first (303, 304) and/or second (500, 600) couplings and powered by a motor to move at least one of the first (303, 304) and second (500, 600) couplings relative to one another to provide powered engagement and disengagement between the first (303, 304) and second (500, 600) couplings and to allow the hanging assembly to be connected and disconnected from the mainframe; characterised in that: the hanging assembly comprises at least a pair of telescopic arms mounted to extend from the carrier frame, each arm comprising one of the second couplings (500, 600).
Walk-behind power equipment, comprising: a main body provided with at least one front wheel and a pair of left and right rear wheels; a work unit provided on the main body; a handle connected to the main body and extending rearward and upward; a tilt angle detection means that detects a tilt angle of the main body; characterized in that the walk-behind power equipment further comprises a pair of left and right travel motors (9L, 9R) provided for the respective rear wheels; a yaw rate detection means that detects a yaw rate generated on the main body; and a control unit that drive-controls the travel motors (9L, 9R), the control unit determines whether the main body is in a rearward tilted state based on the tilt angle, and if it is determined that the main body is not in the rearward tilted state, the control unit performs straight-line travel control to set a rotational speed difference between the left and right travel motors (9L, 9R) to reduce the yaw rate, and if it is determined that the main body is in the rearward tilted state, the control unit does not perform the straight-line travel control. a main body provided with at least one front wheel and a pair of left and right rear wheels; a work unit provided on the main body; a handle connected to the main body and extending rearward and upward; a tilt angle detection means that detects a tilt angle of the main body; characterized in that the walk-behind power equipment further comprises a pair of left and right travel motors (9L, 9R) provided for the respective rear wheels; a yaw rate detection means that detects a yaw rate generated on the main body; and a control unit that drive-controls the travel motors (9L, 9R), the control unit determines whether the main body is in a rearward tilted state based on the tilt angle, and if it is determined that the main body is not in the rearward tilted state, the control unit performs straight-line travel control to set a rotational speed difference between the left and right travel motors (9L, 9R) to reduce the yaw rate, and if it is determined that the main body is in the rearward tilted state, the control unit does not perform the straight-line travel control.
A medicament system which comprises: (a) a solvating system comprising a metal ion sequestering agent and a surfactant that can detach, remove or otherwise disrupt at least a part of a biofilm attached or adhered to at least a portion of the middle or inner ear, to a surface within a nasal or sinus cavity, or to oral or pharyngeal tissue, and (b) a polymeric film-forming medical sealant that can provide a protective layer over a site on which such a biofilm has been disrupted, for use in a method for treating bacterial ear, nose or throat conditions, which method comprises: (i) applying said solvating system to a treatment site comprising a bacterial biofilm attached or adhered to at least a portion of the middle or inner ear, to a surface within a nasal or sinus cavity, or to oral or pharyngeal tissue, (ii) detaching, removing or otherwise disrupting at least a part of the biofilm, and then (iii) applying said polymeric film-forming medical sealant to the treatment site to provide a protective layer that adheres to natural tissues at the site and resists detachment or other disruption until natural degradation or resorption of the sealant takes place. (a) a solvating system comprising a metal ion sequestering agent and a surfactant that can detach, remove or otherwise disrupt at least a part of a biofilm attached or adhered to at least a portion of the middle or inner ear, to a surface within a nasal or sinus cavity, or to oral or pharyngeal tissue, and (b) a polymeric film-forming medical sealant that can provide a protective layer over a site on which such a biofilm has been disrupted, for use in a method for treating bacterial ear, nose or throat conditions, which method comprises: (i) applying said solvating system to a treatment site comprising a bacterial biofilm attached or adhered to at least a portion of the middle or inner ear, to a surface within a nasal or sinus cavity, or to oral or pharyngeal tissue, (ii) detaching, removing or otherwise disrupting at least a part of the biofilm, and then (iii) applying said polymeric film-forming medical sealant to the treatment site to provide a protective layer that adheres to natural tissues at the site and resists detachment or other disruption until natural degradation or resorption of the sealant takes place. (i) applying said solvating system to a treatment site comprising a bacterial biofilm attached or adhered to at least a portion of the middle or inner ear, to a surface within a nasal or sinus cavity, or to oral or pharyngeal tissue, (ii) detaching, removing or otherwise disrupting at least a part of the biofilm, and then (iii) applying said polymeric film-forming medical sealant to the treatment site to provide a protective layer that adheres to natural tissues at the site and resists detachment or other disruption until natural degradation or resorption of the sealant takes place.
A sealing device for a slidable casement as a sliding casement or slidable lifting and sliding casement of a window or a door, consisting of sealing strips (11, 12) arranged in an abutment area between the sliding casement and a fixed field as well as between the sliding casement and a window frame for sealing and securing a gap forming an interspace of a closed sliding casement of the window or a door, of which, in the abutment area, a first sealing strip is fastened to a contact surface of an upper horizontal casement frame portion (5") and a further first sealing strip is fastened to a contact surface of a vertical casement frame portion of the sliding casement, wherein, opposite the first sealing strips of the sliding casement, a second sealing strip is allocated and fastened to a contact surface of an upper horizontal window frame portion of the window frame and a further second sealing strip is allocated and fastened to a contact surface of a vertical fixed-field frame portion of a fixed-field frame of the further fixed field, wherein the first and second sealing strips (11, 12), which consist of a profile body, have profile portions, which, with the sliding casement closed, engage over or behind, resp., one another and form an operatively connected abutment with oppositely arranged first and second seals, respectively facing the strips, wherein the first sealing strips have a first molded part at their free ends, which connects the vertical and horizontal first sealing strips into a structural unit, and the second sealing strips have a second molded part at their free ends, which connects the vertical and horizontal second sealing strips into a structural unit, wherein the first and second sealing strips (11, 12) and the first and second molded parts (16, 17) together with the respective first and second seals are guided around at least one corner of the sliding casement at an angle of about 90 ° in an uninterrupted and circumferential manner and seal the abutment area in a gap-free securing manner, wherein the first seal in a receiving groove of the first sealing strip and in a guiding groove of the first molded part, on the side facing the sliding casement, rests against the second sealing strip and the second molded part in a circumferential manner, and the second seal in a receiving groove of the second sealing strip and in a guiding groove of the second molded part, on the side facing the window frame and the fixed-field frame, rests against the second sealing strip and the first molded part in a circumferential manner, and the first seal is held in the receiving groove of the first sealing strip and in the guiding groove of the first molded part in a form-fittingly guided manner, and the second seal is held in the receiving groove of the second sealing strip and in the guiding groove of the second molded part in a form-fittingly guided manner.
A medical device comprising: an elongated body having a wall that defines a first lumen, a stiffener embedded in the wall, and a sensor lumen positioned in the wall, the stiffener surrounding the first lumen; and a sensor positioned at least partially in the sensor lumen; a transmission line extending through the sensor lumen and coupled to the sensor, where the sensor lumen is separate from the first lumen so as not to be in direct fluid communication with the first lumen and does not impinge on the first lumen, the elongated body has a first end and a second end, and the first lumen extends from the first end to the second end such that both the first and second ends are open, characterised in that the transmission line and the sensor are secured to the sensor lumen (612 using an embedding material. an elongated body having a wall that defines a first lumen, a stiffener embedded in the wall, and a sensor lumen positioned in the wall, the stiffener surrounding the first lumen; and a sensor positioned at least partially in the sensor lumen;
A pump cover for a fuel pump, the fuel pump being disposed on a pump mounting surface defined on the cylinder head of an engine, and the pump cover being located at a position lateral to the fuel pump, the pump cover characterized by comprising: a plate fixed to a side surface of the engine, the plate extending to a position lateral to the fuel pump disposed on the cylinder head; and a rib that protrudes from the plate, the rib being located superjacent to the pump mounting surface, and a bottom surface of the rib being configured to contact the pump mounting surface during a collision. a plate fixed to a side surface of the engine, the plate extending to a position lateral to the fuel pump disposed on the cylinder head; and a rib that protrudes from the plate, the rib being located superjacent to the pump mounting surface, and a bottom surface of the rib being configured to contact the pump mounting surface during a collision.
A method for monitoring hoisting ropes in an elevator system, comprising: measuring tension of each hoisting rope; calculating a mean value of the tension in the hoisting ropes; determining if the tension in any hoisting rope is significantly higher than the mean value; and providing a signal that rope snag has been detected if the tension in any hoisting rope is significantly higher than the mean value; characterized in that the method further comprises: measuring tension of each hoisting rope while an elevator car is parked at a floor; calculating rope frequency and rope amplitude of each rope sway based on periodical fluctuation of the tension; and moving an elevator car to a predetermined refuge floor if the rope amplitude is higher than a predetermined level. measuring tension of each hoisting rope; calculating a mean value of the tension in the hoisting ropes; determining if the tension in any hoisting rope is significantly higher than the mean value; and providing a signal that rope snag has been detected if the tension in any hoisting rope is significantly higher than the mean value; characterized in that the method further comprises: measuring tension of each hoisting rope while an elevator car is parked at a floor; calculating rope frequency and rope amplitude of each rope sway based on periodical fluctuation of the tension; and moving an elevator car to a predetermined refuge floor if the rope amplitude is higher than a predetermined level.
A film of sp 3 -bonded boron nitride on a substrate excellent in field electron emission, wherein a surface texture allowing excellent in field electron emission, formed in a self-organized manner, comprises discrete dots of protrusions each having a sharp tip end, and the discrete dots of protrusions are separated from each other at an interval or distributed at a density suitable for field electron emission.